Wcm Investment Managementca buys $398,492,274 stake in Core Laboratories N.V. (CLB)

Core Laboratories N.V. (CLB) : Wcm Investment Managementca scooped up 217,755 additional shares in Core Laboratories N.V. during the most recent quarter end , the firm said in a disclosure report filed with the SEC on May 9, 2016. The investment management firm now holds a total of 3,406,208 shares of Core Laboratories N.V. which is valued at $398,492,274.Core Laboratories N.V. makes up approximately 6.41% of Wcm Investment Managementca’s portfolio.

Other Hedge Funds, Including , Congress Asset Management Co boosted its stake in CLB in the latest quarter, The investment management firm added 35,025 additional shares and now holds a total of 282,850 shares of Core Laboratories N.V. which is valued at $33,090,622. Core Laboratories N.V. makes up approx 0.82% of Congress Asset Management Co’s portfolio. Teachers Advisors Inc added CLB to its portfolio by purchasing 35 company shares during the most recent quarter which is valued at $4,375.Montag Caldwell reduced its stake in CLB by selling 26 shares or 0.58% in the most recent quarter. The Hedge Fund company now holds 4,420 shares of CLB which is valued at $552,544. Core Laboratories N.V. makes up approx 0.01% of Montag Caldwell’s portfolio.Telemus Capital boosted its stake in CLB in the latest quarter, The investment management firm added 3,493 additional shares and now holds a total of 14,701 shares of Core Laboratories N.V. which is valued at $1,964,936. Core Laboratories N.V. makes up approx 0.32% of Telemus Capital’s portfolio.

Core Laboratories N.V. closed down -1.71 points or -1.44% at $116.99 with 7,33,459 shares getting traded on Friday. Post opening the session at $118.55, the shares hit an intraday low of $116.25 and an intraday high of $119.58 and the price fluctuated in this range throughout the day.Shares ended Friday session in Red.

On the company’s financial health, Core Laboratories N.V. reported $0.37 EPS for the quarter, based on the information available during the earnings call on Apr 20, 2016. Analyst had a consensus estimate of $0.37. The company had revenue of $153.65 million for the quarter, compared to analysts expectations of $156.67 million. The company’s revenue was down -28.1 % compared to the same quarter last year.During the same quarter in the previous year, the company posted $0.86 EPS.

Many Wall Street Analysts have commented on Core Laboratories N.V.. Company shares were Reiterated by Cowen on Apr 22, 2016 to “Market Perform”, Firm has raised the Price Target to $ 105 from a previous price target of $80 .Company shares were Reiterated by RBC Capital Mkts on Apr 22, 2016 to “Outperform”, Firm has raised the Price Target to $ 137 from a previous price target of $128 .Core Laboratories N.V. was Initiated by Citigroup to “Neutral” on Feb 29, 2016.

Core Laboratories N.V. (Core Lab) is a provider of proprietary and patented reservoir description production enhancement and reservoir management services to the oil and gas industry. These services and products are directed toward enabling its clients to improve reservoir performance and increase oil and gas recovery from their producing fields. The Company operates in three segments: Reservoir Description Production Enhancement and Reservoir Management. The Company provides analytical and field services to characterize properties of crude oil and petroleum products to the oil and gas industry.

Leave a Reply

Core Laboratories N.V. - Is it time to Sell?

Top Brokerage Firms are advising their investors on Core Laboratories N.V.. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.